Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.

Mark T Drayson Stella Bowcock Timothy D Planche Gulnaz Iqbal Guy PrattKwee YongJill Wood Kerry Raynes Helen B Higgins Bryony Dawkins David M Meads Claire T Hulme Anna C PhillipsPeter HawkeyEric LowJanet A Dunn

Published in: Health technology assessment (Winchester, England) (2020)

This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 62. See the NIHR Journals Library website for further project information.

Keyphrases

newly diagnosed
public health
healthcare
health information
quality improvement
mental health
health promotion
multiple myeloma
randomized controlled trial
systematic review
social media
risk assessment
meta analyses
climate change